PHOENIXBIO CO., LTD. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 478 JPY | +0.21% |
|
+0.42% | +2.58% |
| Sales 2022 | 1.32B 8.48M 709M | Sales 2023 | 2.12B 13.61M 1.14B | Capitalization | 2.23B 14.32M 1.2B |
|---|---|---|---|---|---|
| Net income 2022 | -387M -2.48M -207M | Net income 2023 | 493M 3.16M 264M | EV / Sales 2022 | 1.09 x |
| Net cash position 2022 | 288M 1.85M 154M | Net cash position 2023 | 426M 2.73M 228M | EV / Sales 2023 | 0.85 x |
| P/E ratio 2022 |
-4.47
x | P/E ratio 2023 |
6.32
x | Employees | 65 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 44.09% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.21% | ||
| 1 week | +0.42% | ||
| Current month | -0.83% | ||
| 1 month | -1.24% | ||
| 3 months | -4.78% | ||
| 6 months | -12.13% | ||
| Current year | +2.58% |
1 week
467.00
482.00
1 month
461.00493.00
Current year
457.00580.00
1 year
442.00628.00
3 years
442.00834.00
5 years
442.001 490.00
10 years
442.003 775.00
| Managers | Title | Age | Since |
|---|---|---|---|
Takashi Shimada
PSD | President | 65 | 04/02/04 |
Kenji Kuramoto
CHM | Chairman | 67 | 01/05/01 |
| Chief Tech/Sci/R&D Officer | 62 | 01/07/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Kenji Kuramoto
CHM | Chairman | 67 | 01/05/01 |
Takashi Shimada
PSD | President | 65 | 04/02/04 |
Yasuhiro Tamura
ADM | Chief Administrative Officer | 67 | 01/04/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/24/02 | 478 | +0.21% | 13 900 |
| 01/24/01 | 477 | +0.21% | 700 |
| 30/24/30 | 476 | -0.63% | 500 |
| 26/24/26 | 479 | -0.21% | 500 |
| 25/24/25 | 480 | +0.42% | 4,000 |
Delayed Quote Japan Exchange, May 02, 2024 at 09:04 am IST
More quotes
PhoenixBio Co., Ltd. is a Japan-based company mainly engaged in provision of contract research services of drug development, which uses PXB mouse. The PXB Mouse segment is engaged in the development of technology to create PXB Mouse in which more than 70% of mouse livers are replaced with human hepatocytes. The product called PXB Mouse is used in the preclinical process of the discovery of drugs.
Calendar
15/05/2024
- Q4 2023 Earnings Release
| 1st Jan change | Capi. | |
|---|---|---|
| +2.58% | 12.18M | |
| +0.67% | 42.19B | |
| +44.30% | 40.15B | |
| -6.20% | 28.31B | |
| +6.55% | 24.63B | |
| -21.66% | 18.2B | |
| +29.96% | 12.01B | |
| -1.57% | 11.76B | |
| +16.03% | 10.4B | |
| -4.80% | 9.94B |
- Stock Market
- Equities
- 6190 Stock
